ATR Gene Seckel Syndrome Type 1 NGS Genetic DNA Test
Introduction
The ATR Gene Seckel Syndrome Type 1 NGS Genetic DNA Test is a crucial diagnostic tool used to identify mutations in the ATR gene. This genetic condition is associated with Seckel syndrome, characterized by growth retardation, microcephaly, and distinctive facial features. Understanding this syndrome is essential for effective management and treatment options for affected individuals.
What the Test Measures
This test employs Next-Generation Sequencing (NGS) technology to detect specific mutations in the ATR gene. By analyzing a sample of blood or extracted DNA, the test can confirm the presence of genetic alterations that may lead to Seckel syndrome.
Who Should Consider This Test?
Individuals showing symptoms of dysmorphology, such as growth delays or unusual facial features, should consider this test. Additionally, those with a family history of Seckel syndrome or related genetic conditions are encouraged to undergo testing to understand their risk factors.
Benefits of Taking the Test
- Early diagnosis of genetic conditions, leading to timely intervention.
- Informed family planning and risk assessment for future pregnancies.
- Access to specialized medical care tailored to the individual’s needs.
- Peace of mind for families with a history of genetic disorders.
Understanding Your Results
Results from the ATR Gene Seckel Syndrome Type 1 NGS Genetic DNA Test will be provided in a detailed report. A genetic counselor will assist in interpreting the results, helping you understand the implications for health and potential treatment options.
Test Information and Pricing
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| ATR Gene Seckel Syndrome Type 1 NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Booking the Test
To book the ATR Gene Seckel Syndrome Type 1 NGS Genetic DNA Test, please contact us at +2348077798758. We recommend scheduling a genetic counseling session prior to testing, which includes gathering clinical history and creating a pedigree chart of affected family members.
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. Sample types accepted include blood, extracted DNA, or one drop of blood on an FTA card. Ensure you provide a thorough clinical history to facilitate accurate testing.
